Immunoparalysis is a common cause of death for critical care patients with sepsis, during which comprehensive suppression of innate and adaptive immunity plays a significant pathophysiological role. Although the underlying mechanisms are unknown, damage-associated molecular pattern molecules (DAMPs) from septic tissues might be involved. Therefore, we surveyed sera from septic 5 patients for factors that suppress the innate immune response to DAMPs, including adenosine triphosphate (ATP), monosodium urate, and high mobility group box-1. Macrophages, derived from THP-1 human acute monocytic leukemia cells, were incubated with each DAMP, in the presence or absence of sera that were collected from critically ill patients. Secreted cytokines were then quantified, and cell lysates were assayed for relevant intracellular signaling mediators. Sera from 10 septic patients who ultimately did not survive significantly suppressed IL-1β production only in response to extracellular ATP. This effect was most pronounced with sera collected on day 3, and persisted with sera collected on day 7. However, this effect was not observed when THP-1 cells were treated with sera from survivors of sepsis. Septic sera collected at the time of admission (day 1) also diminished intracellular levels of inositol 1,4,5-triphosphate and cytosolic calcium (P < 15 0.01), both of which are essential for ATP signaling. Finally, activated caspase-1 was significantly diminished in cells exposed to sera collected on day 7 (P < 0.05). In conclusion, the sera of septic patients contain certain factors that persistently suppress the immune response to extracellular ATP, thereby leading to adverse clinical outcomes. 
Introduction
Sepsis, a systemic inflammatory response to infection, causes multi-organ failure, severe morbidity, and death Kissoon and Uyeki 2016) ; endothelial dysfunction, metabolic changes, and overwhelming or hyperinflammatory innate immune responses to pathogen-associated molecular patterns have been proposed to be the main underlying mechanisms of this condition. Sepsis-induced immunoparalysis, in which both innate and adaptive immunity are suppressed (Frazier and Hall 2008; Hotchkiss et al. 2013) , is also an active focus of research, since it increases the risk of secondary infections and promotes adverse clinical outcomes (Hotchkiss et al. 2013) . Of note, Fattahi and Ward (2017) identified universal mechanisms that drive sepsis-induced immunosuppression, including reduced antigen processing by innate immune cells, the 10 accumulation of regulatory T cells, and the abundant production of immunosuppressive factors.
Inflammatory responses mediated by innate immunity generally promote healing and microbial clearance, although the massive production of pro-and anti-inflammatory cytokines by macrophages might also lead to pathological inflammation. Primary inflammatory cytokines include tumor necrosis factor-α, interleukin-1β (IL-1β), and IL-6, which mediate acute 15 inflammation (Trikha et al. 2003 ) but also cause cell injury and cell death (Kim et al. 2011) . In turn, injured tissues and dying cells generate damage-associated molecular patterns (DAMPs), which then act on various inflammasomes to promote or suppress inflammation (Guo et al. 2015) .
However, the roles of these DAMPs in sepsis are unknown.
DAMPs stimulate nucleotide oligomerization domain-like receptor (NLR) inflammasomes
to activate caspase-1, which then cleaves pro-IL-1β to generate mature, bioactive IL-1β (Chen and Nuñez 2010; Takeuchi and Akira 2010) . One such inflammasome is NLR protein 3 (NLRP3), which contains an ASC-PYCARD domain (Cai et al. 2014; Lu et al. 2014) and is particularly sensitive to a wide variety of DAMPs including adenosine triphosphate (ATP), crystalline 5 substances, nucleic acids, and hyaluronan (Lamkanfi and Dixit 2014; Vanaja et al. 2015) . In this study, we screened sera from septic patients for the ability to alter innate immune responses to DAMPs and inflammasomes, with the goal of defining mechanisms that drive immunoparalysis during sepsis.
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Materials and Methods
Study design and collection of human sera
This study was approved by the Ethics Committee Review Board of Hiroshima University, and was compliant with the Declaration of Helsinki regarding the review and publication of patient data. Sera were collected from patients admitted to the Department of Emergency and Critical Care 15 Medicine, Hiroshima University Hospital for sepsis, with consent from patients or from a family member. Sepsis was diagnosed according to the American College of Chest Physicians and the Society of Critical Care Medicine Consensus Conference (Singer et al. 2016) . For comparison, sera were also collected with consent from patients > 50 years of age who suffered trauma from any cause, as well as from five healthy volunteers. On the day of admission (day 1), as well as day 3 and 20 day 7, peripheral blood samples were collected into evacuated non-EDTA VENOJECT ® II tubes (Terumo, Somerset, NJ, USA) through an indwelling arterial line or a peripheral vein. Blood samples were allowed to clot for ≥ 30 min at room temperature, and sera were obtained by centrifugation at 3,000 g for 10 min and then stored at −80 °C for further analysis. (Gibco) media with 10 % fetal bovine serum (Gibco) and 100 U/mL penicillin/streptomycin (Thermo Fisher) and differentiated for 48 h with 0.5 μM phorbol 12-myristate 13-acetate. Media were then removed, and cells were exposed to sera diluted 60 , with or without DAMPs including 5 2.0 mM ATP (Laliberte et al. 1999) , 200 μg/mL monosodium urate (Gicquel et al. 2015) , and 1 μg/mL HMGB1 (Robert et al. 2010) ; this incubation proceeded for 8 h. The resulting culture supernatant was collected, centrifuged at 40,000 rpm for 10 min at 4 °C, and transferred to 1.5-mL centrifuge tubes for immediate quantification of IL-1β or stored at −20 °C for further experiments.
For the vehicle control condition, THP-1 macrophages were incubated with serum-free RPMI 
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ATP assays
Extracellular and intracellular ATP levels were quantified using an ATP Detection Kit (Invitrogen) according to the manufacturer's instructions. Readings at 450 nm were obtained using a spectrophotometer (Perkin Elmer, Courtaboeuf, France).
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Statistical analysis
Data were analyzed using SPSS 22 (IBM, Armonk, NY, USA). Categorical variables were compared by the Fisher's exact test, whereas multiple groups of normally distributed, unpaired data
on an interval scale were tested by a one-way analysis of variance, and then compared pairwise by 
Results
Cytokine and chemokine profiles of sera from septic patients
The characteristics of critically ill patients and healthy volunteers are listed in Table 1 .
Septic patients were further stratified as shown in Table 2 . Because of inflammation, serum levels 5 of C-reactive protein and lactate at the time of patient admission (day 1) were significantly higher in septic patients than in trauma patients, as previously observed during the acute phase (Póvoa 2002; Jain et al. 2011; Jin et al. 2014; Markanday 2015) . Similarly, IL-1β, IL-6, IL-8, IL-10, IL-18, interferon-, macrophage inflammatory protein-1, and tumor necrosis factor-α were significantly elevated in sera from septic patients as compared with those in sera from trauma patients (Fig. 1) ; in 10 contrast, interferon-γ, IL-23, IL-12, IL-17, and IL-33 were barely detectable in < 30% of all serum samples (data not shown). These observations are concordant with previous studies on innate immunity during acute-phase sepsis, during which pro-and anti-inflammatory responses were both found to be exaggerated (Póvoa 2002; Giannoudis et al. 2004; Kirchhoff et al. 2009; Jaffer et al. 2010; Saraiva and O'Garra 2010; Jain et al. 2011; Jin et al. 2014; Reikeras et al. 2014 ).
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DAMP-specific anti-inflammatory activity of sera from septic patients
After exposing THP-1 macrophages to patient sera, the resulting culture supernatant was tested for IL-1β levels. Strikingly, sera collected from septic patients at the time of admission tended to suppress the in vitro production of IL-1β by macrophages; however, sera from trauma 20 patients or healthy volunteers did not ( Fig. 2A ). This result suggests that septic sera, collected at the time of patient admission, are likely predominantly anti-inflammatory, despite enhanced levels of both pro-and anti-inflammatory cytokines. Further, upon stimulation with each known DAMP in the presence of patient sera, IL-1β production was suppressed only in response to extracellular ATP (Fig. 2B ), but not in response to monosodium urate or HMGB1 (Fig. 2C, D) . Similar analysis of 5 septic sera collected on days 3 and 7 after admission indicated prominent suppression of ATP-induced IL-1β production by sera collected on day 3. This activity persisted with sera collected on day 7 from patients who ultimately did not survive; however, this was not the case when using sera collected on day 7 from patients who survived (Fig. 3A) . As with sera collected on day 1, day 3, and day 7, these trends were not observed in macrophages stimulated with monosodium urate (Fig.   10 3B). The observed loss of ATP-induced IL-1β production was not due to serum-induced apoptosis, as cell viability after 8 h was comparable among all cells (data not shown). Therefore, we hypothesize that sera from septic patients have inherent anti-inflammatory functions and might contain factor(s) that suppress the response to extracellular ATP.
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Possible anti-inflammatory mechanisms of septic sera
Extracellular ATP is known to trigger IL-1β production in macrophages by acting on NLRP3
inflammasomes via purinergic pathways that depend on P2X, P2Y, and adenosine P1 receptors (Baron et al. 2015 hypothesized that the observed loss of ATP-induced IL-1β production could be due to ATP hydrolysis by ATPases in sera from septic patients, inhibition of P2X 7 , or inhibition of NLRP3.
ATPase activity in sera from septic patients is negligible
Using a luciferase-based assay, we compared ATP levels in supernatants after incubating 10 macrophages with ATP and the sera from healthy donors, trauma patients, or septic patients. We found that ATP levels were similar among these groups (Fig. 4A ). In addition, residual ATP in sera probably did not affect macrophage activity since these samples were diluted such that ATP levels would be negligible before addition to cells (Fig. 4B) . These results suggest that ATPase activity in patient sera, if any, did not significantly affect IL-1β production in response to extracellular ATP.
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Septic sera from non-survivors activates the P2X 7 channel
As previously reported, the uptake of YO-PRO-1 or other large, positively charged tracers is a direct measure of P2X 7 activity (Cankurtaran-Sayar et al. 2009; Baron et al. 2015) . Thus, THP-1 macrophages stimulated with ATP and patient sera were stained with YO-PRO-1 and analyzed by 20 13 flow cytometry. The mean fluorescence intensity was comparable among macrophages treated with sera from healthy controls, trauma patients, or septic patients (Fig. 4C) . However, this was higher in macrophages treated with sera collected on days 1 and 7 from patients who did not survive than in cells treated with sera from septic patients who survived (P < 0.05; Fig. 4D ). In the presence of 10 μM A-740003, a specific inhibitor of P2X 7 , the mean fluorescence intensity was dramatically 5 diminished in all cells including those treated with sera from non-survivors (data not shown). These observations suggest that septic sera from non-survivors enhance P2X 7 activity.
Inhibition of pro-inflammatory pathways by septic sera
Cell lysates were then subjected to the detection of cytosolic mediators associated with the 10 ATP-dependent inflammasome pathway after exposure to ATP in the presence of patient sera.
Intracellular ATP was slightly lower in macrophages treated with sera collected from septic patients on day 1 than in cells treated with sera from trauma patients (Fig. 5A) . Accordingly, levels of inositol 1,4,5-triphosphate and cytosolic calcium were significantly lower in the former group than in the latter, as well as compared to those in cells exposed to sera from healthy controls (P < 0.01;
15 Fig. 5B, C) . However, these effects were largely absent in cells treated with sera collected on day 7 from septic patients. In contrast, cyclic AMP levels were comparable among all cell groups (Fig.   5D ). Collectively, these data indicate that sera collected from septic patients at the time of admission suppress pro-inflammatory pathways upstream of NLRP3.
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Sera from septic patients who did not survive suppress caspase-1 activation
Pro-IL-1β, which is processed to form IL-1β following NLRP3 and caspase-1 activation, was slightly more abundant in cells treated with sera from septic patients collected on days 1 and 7 than in cells exposed to sera from healthy controls or trauma patients (Fig. 6A) . Conversely, active caspase-1 was significantly less abundant in macrophages treated with sera from septic patients 5 collected on day 1 (P < 0.01), but not in cells stimulated with sera collected on day 7 from septic patients (Fig. 6B) . However, the significant decrease in active caspase-1 was also observed in cells treated with sera collected on day 7 from patients who did not survive (P < 0.05; Fig. 6C ). Similar trends were observed in terms of intracellular IL-1β levels (Fig. 6D, E) . Taken together, these data suggest that activation of NLRP3 and caspase-1 in response to extracellular ATP is suppressed by 10 factors that are present in sera from septic patients. This suppressive effect is clearly associated with prolonged immunoparalysis and poor clinical outcomes since it was found to be more pronounced in sera collected from patients who did not survive.
Discussion
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Our data indicated that sera from septic patients suppress IL-1β production in macrophages stimulated with extracellular ATP, likely by antagonizing upstream NLRP3 or pro-inflammatory pathways. This suppressive effect peaked on day 3 after admission and persisted until day 7 among patients who did not survive, but was lost by day 7 among patients who survived. These observations suggest a new mechanism through which sepsis mediates 20 immunoparalysis, and partially support the prior hypothesis that persistent suppression of innate and adaptive immunity can cause late-stage death in septic patients (Hotchkiss et al. 2013 ).
Inflammation and cell death in critically ill patients results in the abundant generation of DAMPs, which induce pro-inflammatory cytokine production (Cauwels et al. 2014; Stoffels et al. 2015; Timmermans et al. 2016) . Of the known DAMPs, extracellular ATP is one of the most potent. immunosuppressive cytokine, in a dose-dependent manner (Seo et al. 2004) . They can also impair neutrophil chemotaxis and host defense during sepsis (Li et al. 2017) . Therefore, ATP balance in the extracellular microenvironment is critical for the modulation of innate and adaptive immunity.
Immunosuppressive factors have been detected in vivo and in vitro in sera from patients with 15 active tuberculosis, cirrhosis, and solid tumors (Sherwin et al. 1979; Sugiyama et al. 1987; O'Brien et al. 2014; Kano 2015) . In sera from septic patients, common immunosuppressive factors have also been detected, including IL-10, transforming growth factor β, and IL-4; these cytokines suppress pro-inflammatory mediators, tissue repair, T cell proliferation, and differentiation, among other functions, but also accelerate fibrosis and the development of T regulatory cells (Schulte et al. 20 2013). Similarly, in our study, septic sera that were collected during early clinical phases were found to contain immunosuppressive factors including IL-10, which is known to repress cytokine production in lipopolysaccharide-stimulated peritoneal macrophages (Fiorentino et al. 1991) .
However, the role of IL-10 in ATP-induced IL-1β production is unknown, especially since neutralizing antibodies to IL-10 did not affect the response of THP-1 macrophages to extracellular 5 ATP (data not shown). Thus, sera from septic patients likely contain suppressive factors independent of IL-10.
Our data also suggested that sera from septic patients who did not survive enhance P2X 7 uptake (Fig. 3D) , which might partly explain the edema and cell swelling typically observed in septic patients. However, further studies are required to test this hypothesis. A lack of data regarding 10 ATP trafficking is also a limitation of this study. For example, we observed that intracellular ATP levels were comparable upon stimulation with sera from septic patients who survived and those from non-survivors, probably as a result of autoregulatory mechanisms in the cytosol. Such mechanisms include the opening of pannexin pores to release ATP and IL-1β into the extracellular space, as well as feedback regulation by adenosine, which itself is regulated by membrane-bound 15 nucleotide transporters and by intracellular adenosine kinase (Baron et al. 2015) . Finally, the number of non-surviving patients was too small to investigate the relationship between a potential novel mechanism of immunoparalysis and mortality. Thus, we recommend larger multicenter studies, especially using non-survivors.
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Conclusion
In conclusion, we show that immunoparalysis in septic patients could be caused by serum factor(s) that suppress the inflammatory IL-1β response to extracellular ATP by inhibiting caspase-1 activation in innate immune cells. Such suppressive factors might be correlated with fatal outcomes. 
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Disseminated Intravascular Coagulation was calculated based on JAAM-DIC 2016. Sera collected at the time of patient admission were screened by bead-based fluorescence assays to quantify inflammatory cytokines, with a limit of quantification of 0.6 pg/mL. Individual 5 serum samples were assayed in duplicate and averaged (healthy controls, n = 5; trauma patients, n = 10; sepsis patients, n = 49). *P < 0.05; **P < 0.01 by Mann-Whitney U test. Individual serum samples were assayed in triplicate and averaged (healthy controls, n = 5; trauma patients, n = 10; sepsis patients, n = 49). **P < 0.01 by Mann-Whitney U test. Individual sera were assayed in triplicate and averaged (sepsis survivors on day 1, n = 39; sepsis 20 non-survivors on day 1, n = 10; sepsis survivors on day 3, n = 16; sepsis non-survivors on day 3, n = 4; sepsis survivors on day 7, n = 16; sepsis non-survivors on day 7, n = 4). *P < 0.05, by 2 test. Fig. 4 . Sera from septic patients who did not survive activate P2X 7 uptake.
A-B. ATP in the culture supernatant was quantified by a luciferin-luciferase assay using the (untreated) or with the indicated agent and sera diluted 60 . Individual sera were tested in triplicate and averaged (healthy controls, n = 5; trauma patients, n = 10; sepsis patients on day 1, n = 49; sepsis patients on day 7, n = 20; sepsis survivors on day 1, n = 39; sepsis non-survivors on day 1, n = 10; sepsis survivors on day 7, n = 16; sepsis non-survivors on day 7, n = 4). *P < 0.05 by Mann-Whitney U test; n.s., not significant by ANOVA. Lysates from macrophages exposed to ATP and sera were assayed by ELISA for intracellular ATP (A), inositol 1,4,5-triphosphate (B), cytosolic calcium (C), and cyclic AMP (D).
Macrophages were treated with RPMI supplemented without (untreated) or with the indicated 20 agent and sera diluted 60 . Individual sera were assayed in triplicate and averaged (healthy controls, n = 5; trauma patients, n = 10; sepsis patients on day 1, n = 49; sepsis patients on day 7, n = 20). *P < 0.05; **P < 0.01 by Mann-Whitney U test or 2 test. and averaged (healthy controls, n = 5; trauma patients, n = 10; sepsis patients on day 1, n = 49; sepsis patients on day 7, n = 20; sepsis survivors on day 1, n = 39; sepsis non-survivors on day 1, n = 10; sepsis survivors on day 7, n = 16; sepsis non-survivors on day 7, n = 4). *P < 0.05; **P 
